Valence today announced plans to integrate select Harvard Business Review (HBR) content into Nadia, Valence's enterprise AI coaching platform. The content will be provided through a collaboration with ...
Partnership will provide access to Valence’s machine learning platform to accelerate preclinical drug discovery efforts Building on research done by Valence’s founding team at Mila, the world’s ...
Valence Security, the leader in SaaS security, announced today its SaaS discovery capabilities to uncover shadow IT and manage SaaS sprawl. Extending Valence's leading SaaS security posture management ...
SALT LAKE CITY and TORONTO and MONTRÉAL, May 08, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today ...